It comprises a new formula that is able to maintain a lower skin pH for a longer time – up to 12 hours.
Its lower pH also allows for the restoration of the skin barrier against environmental insults.
Currently, Ceradan Advanced’s formula is patent-pending and will be available in clinics and retail pharmacies in hospitals.
Meanwhile, the group will be extending its existing Ceradan emollient to pharmacy chains in Singapore.
Lim See Wah, executive chairman and CEO of Hyphens Pharma, says, “We will be working closely with doctors who will appreciate the benefit of this advanced skin buffering system, availing the product to help patients who seek medical attention. We will also now expand the access of our current Ceradan range through the OTC channels, making Ceradan readily available to consumers.”
Shares in Hyphens Pharma closed 2.44% higher on Wednesday at 21 cents.
